Author Claim Review

 Quick Explanation Copied

 Long Explanation

Career Arc and Citation Footprint

Oded Kleifeld's OpenAlex profile (ORCID 0000-0003-3091-7154) shows 108 works, 5,833 citations, and an h-index of 37 — far higher than the Semantic Scholar fragment (h-index 7, 171 citations, 20 papers), illustrating how author-disambiguation and database coverage dramatically change perceived metrics. The OpenAlex record is the more complete one and is used here Field-defining MMP review, 1,216 citations.

Two works dominate his impact: the MMP review (1,216 citations) and his first-author TAILS method paper in Nature Biotechnology (546 citations), followed by the Nature Protocols TAILS protocol (315 citations) and a 2014 Cell Reports study on reversible 26S proteasome disassembly under mitochondrial stress (188 citations) TAILS Nature Protocols paper 26S proteasome disassembly under stress.

Role Pattern: Methodologist and Enabling Collaborator

The authorship pattern is telling. Kleifeld is first author on methodological innovations (TAILS, LysargiNase) and middle/last author on application papers spanning ubiquitin-proteasome biology with Michael Glickman at Technion, structural pore-forming protein biology at Monash, and gonococcal pathogenesis LysargiNase protease, Nature Methods Gonococcal OMV PorB apoptosis study. His recent portfolio is strikingly broad — proteasome-associated DUBs, viral NblA effects on cyanobacteria, desert algal photoprotection, cannabinoid combinations in mouse colitis, computational MMP-9 design — indicating a proteomics core-facility or senior-research-scientist role serving many labs rather than a single sustained independent program.

Strengths, Blindspots, and Uncertainty

Strengths: deep mass-spectrometry proteomics expertise, co-invention of a field-standard N-terminomics method with lasting citation traction, publication in top journals (Nature Biotechnology, Nature Methods, Nature Communications, Cell Reports, Molecular Cell), and ~20 years of continuous output Standalone 20S proteasome study.

Blindspots: citation counts are heavily inflated by two legacy works (2006, 2010); recent works (2020–2026) accrue modest citations (23–378 total per year, mostly from the 2021 mitophagy paper), and the 2026 works have zero citations so far. The listed affiliation field is empty, and the split between Semantic Scholar and OpenAlex records adds uncertainty about true publication count. Whether recent applied papers (e.g., CBD/CBDV in colitis, mouse models) replicate independently is unknown from citation data alone — small-animal studies in this area have reproducibility concerns generally.

Verdict basis: an h-index of 37 with 5,833 citations places Kleifeld among established, well-cited researchers, but the concentrated early impact and breadth-over-depth recent pattern indicate high technical/analytical skill with less evidence of independent conceptual leadership. Confidence: moderate — based solely on bibliometric records, not full-text review of methods quality.

 BGPT Author Review

Scientific Quality

H-index 37 with two landmark contributions (MMP drug-target review; TAILS invention) demonstrates genuine methodological impact. However, most citation mass comes from two legacy papers, recent works are largely collaborative applications, and there is no clear evidence of an independent research vision. Scores are bibliometric-based and uncertain due to database disambiguation.

Communication Quality

Publications in top-tier journals with structured protocols (Nature Protocols) imply clear technical writing, but no evidence of reviews, commentaries, or outreach is available; communication quality is inferred, not directly assessed.

Author Novelty

TAILS was a genuinely novel N-terminomics method with hundreds of citations, and LysargiNase extended the protease toolkit. Later work applies existing methods to diverse systems rather than introducing new concepts.

Scientific Rigor

Method papers in Nature Biotechnology/Methods and protocols journals demand high rigor, and long-lived method adoption implies reproducibility. Rigor of recent applied mouse and algal studies cannot be verified from bibliometric data alone.